Volume 89 Issue 49 | p. 21 | Concentrates
Issue Date: December 5, 2011

Elan And Cambridge Set Up R&D Center

Department: Business
Keywords: Alzheimer’s, academic-industry cooperation

Elan Corp. and the University of Cambridge are launching a drug discovery center focused on therapies for both Alzheimer’s and Parkinson’s diseases. To be based in Cambridge’s chemistry department, the center will search for new therapies that are able to interrupt the production of amyloid-β, a protein associated with Alzheimer’s. Elan will invest $10 million over the first five years of what is to be a 10-year collaboration.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment